Novo Nordisk A/S: Kidney Diseases trials

The registry lists 16 Kidney Diseases studies with Novo Nordisk A/S as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 2Phase 2 2Phase 3 3Phase 4 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2CompletedNCT03847909Phase 2Results posted
• A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT03819153Phase 3Results posted
• Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or ParentsCompletedNCT01245374Phase 4Results posted
• The Effect of Somatropin Treatment in Adult Patients on Chronic DialysisTerminatedNCT00503698Phase 3Results posted
• SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world DataCompletedNCT06769646
• A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among NephrologistsCompletedNCT06322641
• Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)CompletedNCT06122961
• A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among CardiologistsCompletedNCT05755373
• A Research Study Looking Into Levels of the Medicine NNC0385-0434 in the Body and How Well it is Tolerated in Participants With Impaired Kidney Function Compared to Participants With Normal Kidney FunctionTerminatedNCT05094934Phase 1
• Long Term Extension Study in Patients With Primary HyperoxaluriaActive, not recruitingNCT04042402Phase 3
• Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic HaemodialysisCompletedNCT01502137Phase 1
• Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth HormoneCompletedNCT01327924
• Observational Prospective Study on Patients Treated With Norditropin®CompletedNCT00960128
• Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney DiseaseWithdrawnNCT00849316
• Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.CompletedNCT00184769Phase 4
• Growth Hormone Treatment in Adult Patients With Chronic Kidney DiseaseCompletedNCT00184652Phase 2